Difficulty: Medium
Average Score: 83%
Practice
The mechanism of amantadine action is:
Correct answer
B
Rationale
The correct answer is B) Blocking the excitatory cholinergic system. Amantadine is an antiviral and antiparkinsonian drug that also has some activity in the treatment of dyskinesias. It exerts its pharmacological effects by blocking the action of excitatory cholinergic neurotransmission in the brain, particularly in the basal ganglia. By blocking the excitatory effects of acetylcholine, amantadine helps to rebalance neurotransmitter activity in conditions such as Parkinson's disease and drug-induced movement disorders.
Option A) Stimulating the glutamatergic neurotransmission is incorrect because amantadine does not directly affect glutamatergic neurotransmission.
Option C) Inhibition of dopa decarboxylase is incorrect because this mechanism is associated with drugs like carbidopa, which is used in combination with levodopa for the treatment of Parkinson's disease.
Option D) Selective inhibition of catechol-O-methyltransferase is incorrect because drugs like entacapone and tolcapone are known for this mechanism in the treatment of Parkinson's disease, but not amantadine.
Understanding the mechanism of action of drugs is crucial for pharmacology students and healthcare professionals to make informed decisions about drug therapy based on the underlying pathophysiology of the condition being treated. In this case, knowing that amantadine blocks excitatory cholinergic neurotransmission helps in understanding its therapeutic effects in specific conditions.
Option A) Stimulating the glutamatergic neurotransmission is incorrect because amantadine does not directly affect glutamatergic neurotransmission.
Option C) Inhibition of dopa decarboxylase is incorrect because this mechanism is associated with drugs like carbidopa, which is used in combination with levodopa for the treatment of Parkinson's disease.
Option D) Selective inhibition of catechol-O-methyltransferase is incorrect because drugs like entacapone and tolcapone are known for this mechanism in the treatment of Parkinson's disease, but not amantadine.
Understanding the mechanism of action of drugs is crucial for pharmacology students and healthcare professionals to make informed decisions about drug therapy based on the underlying pathophysiology of the condition being treated. In this case, knowing that amantadine blocks excitatory cholinergic neurotransmission helps in understanding its therapeutic effects in specific conditions.